Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /pdfs/ Disallow: /*.jpg$ |
Title | Anthos |
Description | Accelerating the development of life-preserving therapies for patients at high-risk of cardiovascular |
Keywords | N/A |
WebSite | anthostherapeutics.com |
Host IP | 23.229.183.105 |
Location | United States |
Site | Rank |
US$7,265,866
Last updated: 2022-07-22 19:13:14
anthostherapeutics.com has Semrush global rank of 1,456,716. anthostherapeutics.com has an estimated worth of US$ 7,265,866, based on its estimated Ads revenue. anthostherapeutics.com receives approximately 838,370 unique visitors each day. Its web server is located in United States, with IP address 23.229.183.105. According to SiteAdvisor, anthostherapeutics.com is safe to visit. |
Purchase/Sale Value | US$7,265,866 |
Daily Ads Revenue | US$6,707 |
Monthly Ads Revenue | US$201,209 |
Yearly Ads Revenue | US$2,414,504 |
Daily Unique Visitors | 55,892 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
anthostherapeutics.com. | A | 599 | IP: 23.229.183.105 |
anthostherapeutics.com. | NS | 3600 | NS Record: ns55.domaincontrol.com. |
anthostherapeutics.com. | NS | 3600 | NS Record: ns56.domaincontrol.com. |
anthostherapeutics.com. | MX | 3600 | MX Record: 10 anthostherapeutics.com.1.0001.arsmtp.com. |
anthostherapeutics.com. | MX | 3600 | MX Record: 20 anthostherapeutics.com.2.0001.arsmtp.com. |
anthostherapeutics.com. | TXT | 3600 | TXT Record: c6IYZdGpx8toJH7uDO224A== |
anthostherapeutics.com. | TXT | 3600 | TXT Record: v=verifydomain MS=4542475 |
anthostherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 mx include:edgepilot.com include:anthostherapeutics-com.spf.smtp25.com ~all |
Home - Logo About Anthos Our Science A Major Unmet Need The Promise of Factor XI Inhibition About Abelacimab Our Team News Investors Contact Us Twitter Linkedin ANTHOS THERAPEUTICS Accelerating the development of life-preserving therapies for patients at high-risk of cardiovascular and metabolic diseases. Read More ANTHOS THERAPEUTICS Accelerating the development of life-preserving therapies for patients at high-risk of cardiovascular and metabolic diseases. Read More Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated innovative therapies to advance care for people living with cardiovascular and metabolic (CVM) diseases. Read More Our Science Our most advanced program is abelacimab, an investigational monoclonal antibody that achieves profound suppression of the novel antithrombotic target Factor XI through dual activity against both Factor XI itself and its activated form, |
HTTP/1.1 200 OK Date: Thu, 04 Nov 2021 16:23:16 GMT Server: Apache X-Powered-By: PHP/7.4.23 Upgrade: h2,h2c Connection: Upgrade Last-Modified: Thu, 04 Nov 2021 12:44:42 GMT Content-Type: text/html; charset=UTF-8 |
Domain Name: ANTHOSTHERAPEUTICS.COM Registry Domain ID: 2265845260_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-26T16:02:04Z Creation Date: 2018-05-21T15:41:06Z Registry Expiry Date: 2023-05-21T15:41:06Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS55.DOMAINCONTROL.COM Name Server: NS56.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-22T08:34:58Z <<< |